MOLECULAR BASIS OF ANTIGENIC SPECIFICITY
抗原特异性的分子基础
基本信息
- 批准号:3445764
- 负责人:
- 金额:$ 5.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-06-01 至 1989-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Preliminary thermodynamic studies of a high affinity monoclonal
anti-fluorescyl antibody (4-4-20) indicate that its active site is a
shallow hydrophobic pocket, which binds fluorescein primarily through
entropy. Moreover, high resolution diffraction data (2.5 Angstrom) is
available for the liganded antigen binding fragment (Fab) of this antibody,
which crystallizes in 16% polyethyleneglycol. Liganded Fab fragments also
crystallize in a less polar solvent system (46.7%
2-methyl-2,4-pentanediol). The affinity of the intact IgG molecule is
300-fold lower in this solvent. Correlated crystal and solution studies of
both crystal systems are planned. With this information we hope to explain
the molecular basis of antigen binding to this antibody. Crystallization
trials are currently in progress with four other monoclonal anti-fluorescyl
antibodies which are idiotypically related to 4-4-20, but exhibit
affinities which vary over a 1000-fold range. Solution studies are planned
to determine whether the entropy predominance and active site
characteristics of 4-4-20 are common to the other clones as well.
Idiotypic determinants are generally thought to be located at or near the
active site. Crystal studies should clarify the nature of idiotypic
determinants and whether idiotypic reagents are valid tools for identifying
related active sites.
High resolution diffraction data (2.0 Angstrom) is available for the
unliganded Fab fragment of a monoclonal antibody which binds single
stranded DNA (BV04-01). In solution, the protein exhibited a base
specificity for pyrimidines, with greater affinity for thymine than
uracil. This antibody is of clinical importance because it was isolated
from a mouse with an autoimmune syndrome similar to systemic lupus
erythematosus. We have obtained a low-resolution (6 Angstrom) structure
and plan to extend this solution to higher resolution. We also plan to
perfuse oligonucleotides into crystals to determine the molecular basis of
the observed pyrimidine specificity.
一种高亲和力单抗的热力学初步研究
抗荧光素抗体(4-4-20)表明其活性部位为
浅疏水口袋,主要通过以下途径结合荧光素
信息量。此外,高分辨率的衍射数据(2.5埃)是
可用于该抗体的连接抗原结合片段(FAB),
结晶在16%的聚乙二醇中。连接的Fab片段也
在低极性溶剂体系中结晶(46.7%
2-甲基-2,4-戊二醇)。完整免疫球蛋白分子的亲和力为
在这种溶剂中降低300倍。相关晶体和溶液的研究
这两个水晶系统都在计划之中。有了这些信息,我们希望能解释
抗原与这种抗体结合的分子基础。结晶
目前正在对另外四种抗荧光素的单抗进行试验
与4-4-20独特型相关的抗体,但表现为
亲和力在1000倍的范围内变化。计划进行解决方案研究
确定是否具有熵优势和活跃部位
4-4-20的特性也是其他无性系共有的。
独特型决定因素通常被认为位于
活动站点。水晶研究应该澄清独特型的本质
决定因素和独特型试剂是否是识别
相关活动站点。
高分辨率的衍射数据(2.0埃)可用于
与单个抗体结合的单抗的未连接Fab片段
搁浅的DNA(BV04-01)。在溶液中,蛋白质表现出一种碱基
对嘧啶的特异性,与胸腺嘧啶的亲和力比
尿嘧啶。这种抗体具有临床重要性,因为它是被分离出来的。
来自患有类似系统性红斑狼疮的自身免疫综合征的小鼠
红斑狼疮。我们得到了一个低分辨率(6埃)的结构
并计划将该解决方案扩展到更高的分辨率。我们还计划
将寡核苷酸注入晶体以确定其分子基础
观察到的嘧啶专一性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James N Herron其他文献
James N Herron的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James N Herron', 18)}}的其他基金
Novel Reagents and Methods for Rapid and High Throughput Detection of Aflatoxin C
快速高通量检测黄曲霉毒素C的新试剂和方法
- 批准号:
8396243 - 财政年份:2013
- 资助金额:
$ 5.12万 - 项目类别:
Novel Reagents and Methods for Rapid and High Throughput Detection of Aflatoxin C
快速高通量检测黄曲霉毒素C的新试剂和方法
- 批准号:
8739645 - 财政年份:2013
- 资助金额:
$ 5.12万 - 项目类别:
Novel Method and Self Contained System for Reliable Assessment of Potency of Botu
可靠评估博土功效的新方法和独立系统
- 批准号:
8126652 - 财政年份:2011
- 资助金额:
$ 5.12万 - 项目类别:
Novel Method and Self Contained System for Reliable Assessment of Potency of Botu
可靠评估博土功效的新方法和独立系统
- 批准号:
8337736 - 财政年份:2011
- 资助金额:
$ 5.12万 - 项目类别:
相似海外基金
Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
- 批准号:
23H02361 - 财政年份:2023
- 资助金额:
$ 5.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : GNT1124162 - 财政年份:2017
- 资助金额:
$ 5.12万 - 项目类别:
Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : 1124162 - 财政年份:2017
- 资助金额:
$ 5.12万 - 项目类别:
Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9300976 - 财政年份:2015
- 资助金额:
$ 5.12万 - 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9920805 - 财政年份:2015
- 资助金额:
$ 5.12万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8900121 - 财政年份:2012
- 资助金额:
$ 5.12万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8225814 - 财政年份:2012
- 资助金额:
$ 5.12万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8699511 - 财政年份:2012
- 资助金额:
$ 5.12万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8525355 - 财政年份:2012
- 资助金额:
$ 5.12万 - 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
- 批准号:
9115537 - 财政年份:1991
- 资助金额:
$ 5.12万 - 项目类别:
Standard Grant














{{item.name}}会员




